KRAS and neoplasm: Consequently, tyrosine phosphorylation of KRAS in PDAC could interfere with tumor development via KRAS inactivation.215,220 In this context, SFK inhibitors can induce RAS hyperactivation, thereby leading to enhanced RAF/MEK/ERK signaling in PDAC cells.